These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15883102)

  • 41. Is there sufficient evidence for us to encourage the widespread use of hormone replacement therapy to prevent disease?
    Hannaford PC
    Br J Gen Pract; 1998 Feb; 48(427):951-2. PubMed ID: 9624761
    [No Abstract]   [Full Text] [Related]  

  • 42. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Against medicalizing the postmenopause with HRT].
    Guyot B
    Gynecol Obstet Fertil; 2008 Jan; 36(1):104-9. PubMed ID: 18248840
    [No Abstract]   [Full Text] [Related]  

  • 44. [Concerning "risks and benefits of long-term treatment with estrogens" by T.M. Mack and R.K. Ross, Schweiz. med. Wschr. 1989; 119:1811-1820].
    Sitruk-Ware R
    Schweiz Med Wochenschr; 1990 Oct; 120(43):1608-10. PubMed ID: 2251476
    [No Abstract]   [Full Text] [Related]  

  • 45. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hold the hormones? The good and the bad about postmenopausal estrogen therapy.
    Nemecek S
    Sci Am; 1997 Sep; 277(3):38, 40. PubMed ID: 9304196
    [No Abstract]   [Full Text] [Related]  

  • 49. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dehydroepiandrosterone (DHEA) and the menopause: an update.
    Raven PW; Hinson JP
    Menopause Int; 2007 Jun; 13(2):75-8. PubMed ID: 17540138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233
    [No Abstract]   [Full Text] [Related]  

  • 52. [Latin-American position about current state of hormone therapy. Position Statement of the Group of Latin American Experts on Hormonal Therapeutic Materials].
    Grupo de expertos de Latinoamérica en materia de terapia hormonal
    Ginecol Obstet Mex; 2005 Apr; 73(4):205-11. PubMed ID: 21966757
    [No Abstract]   [Full Text] [Related]  

  • 53. [Phytoestrogens--an alternative to hormonal replacement therapy].
    Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
    Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New insights on the effects of hormone replacement therapy on the breast tissue and the orgnaism].
    Kubista E
    Wien Klin Wochenschr; 2003; 115 Suppl 2():46-9. PubMed ID: 15518146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Menopause: estrogen replacement, osteoporosis, and serum lipoproteins.
    Gnatuk CL; Ory SJ
    Curr Opin Obstet Gynecol; 1989 Dec; 1(2):187-94. PubMed ID: 2491121
    [No Abstract]   [Full Text] [Related]  

  • 56. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(2):168-82. PubMed ID: 17259911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk assessment of the menopausal patient.
    Kothari S; Thacker HL
    Med Clin North Am; 1999 Nov; 83(6):1489-502. PubMed ID: 10584604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer and hormone-replacement therapy: up to general practice to pick up the pieces.
    Lagro-Janssen T; Rosser WW; van Weel C
    Lancet; 2003 Aug; 362(9382):414-5. PubMed ID: 12927422
    [No Abstract]   [Full Text] [Related]  

  • 59. [Menopause and hormone therapy].
    Rüedi B
    Rev Med Suisse Romande; 1989 Nov; 109(11):885-7. PubMed ID: 2595161
    [No Abstract]   [Full Text] [Related]  

  • 60. Gauging the benefits, risks, and unknowns of hormone replacement therapy. Exploring HRT.
    Valerie AM
    AWHONN Lifelines; 2002; 6(1):24-31. PubMed ID: 11913199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.